基于药基的虚拟选和结构修改新型胺衍生物作为HBV体组装调节器
Yiyang Qin1, Shengdan Wang1, Yunwen Wang1,2
1College of Pharmaceutical Sciences, Zhejiang University.
Biological & pharmaceutical bulletin
|September 4, 2023
概括
新型胺化合物在对抗乙型肝炎病毒 (HBV) 感染方面显示出显著的前景. 这些新开发的囊组装调节器 (CAMs) 提供了潜在的新治疗策略来对抗HBV,这是全球肝病死亡的主要原因.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药用化学 医学化学
背景情况:
- 乙型肝炎病毒 (HBV) 感染是导致肝病死亡的全球主要原因.
- 开发新的抗病毒疗法对于控制HBV至关重要.
- 囊组装调节器 (CAM) 是对抗HBV的一种有前途的治疗策略.
研究的目的:
- 识别和优化新型乙型肝炎病毒 (HBV) 体组合调节器 (CAM).
- 发现具有强大的抗HBV活性的新化学实体.
主要方法:
- 采用基于药理的虚拟选策略来识别潜在的候选药物.
- 选择了胺基支架 (WAI-5) 作为结构优化的起点.
- 合成和评估了一系列新的HBV CAMs.
主要成果:
- 通过结构优化确定了一系列新的HBV CAM.
- 代表性化合物11g和11n显示,与相比,抗HBV活性增加了10倍.
- 化合物11g的EC50值为1.74μM,而化合物11n的EC50值为1.90μM.
结论:
- 优化的胺衍生物显示出显著增强的抗HBV活性.
- 这些新型CAMs代表了B型肝炎治疗的有希望的候选药物.
- 这些化合物的进一步开发可能会导致HBV感染的有效治疗方法.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.2K
相关概念视频
Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
